“Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders”. Semin Nucl Med32 (1): 13–14. (2002). doi:10.1053/snuc.2002.29276. PMID11839066.
“Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.”. Clin. Cancer Res.11 (8): 2785–2808. (2005). doi:10.1158/1078-0432.CCR-04-2626. PMID15837727.
“Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders”. Semin Nucl Med32 (1): 13–14. (2002). doi:10.1053/snuc.2002.29276. PMID11839066.
“Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.”. Clin. Cancer Res.11 (8): 2785–2808. (2005). doi:10.1158/1078-0432.CCR-04-2626. PMID15837727.